KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to 0.09%.

  • Astrazeneca's Return on Capital Employed rose 200.0% to 0.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.1% for FY2025, which is 200.0% up from last year.
  • Per Astrazeneca's latest filing, its Return on Capital Employed stood at 0.09% for Q4 2025, which was up 200.0% from 0.09% recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Return on Capital Employed registered a high of 0.12% during Q4 2023, and its lowest value of 0.0% during Q2 2022.
  • Its 5-year average for Return on Capital Employed is 0.06%, with a median of 0.06% in 2021.
  • In the last 5 years, Astrazeneca's Return on Capital Employed plummeted by -600bps in 2022 and then surged by 700bps in 2023.
  • Quarter analysis of 5 years shows Astrazeneca's Return on Capital Employed stood at 0.03% in 2021, then surged by 60bps to 0.05% in 2022, then skyrocketed by 121bps to 0.12% in 2023, then tumbled by -37bps to 0.08% in 2024, then rose by 25bps to 0.09% in 2025.
  • Its last three reported values are 0.09% in Q4 2025, 0.09% for Q3 2025, and 0.08% during Q2 2025.